ARCHIVES

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

This article is from The Cancer Letter archive.

Vol. 19 No. 14 | April 2, 1993

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Recompetition Of Clinical Trials, Other Contracts, New BNCT Grants

October 28, 1988

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

NTP Board Approves Six New Projects, Tables One Other

January 23, 1981

Five Awards Expected In Annual CCP Review; 21 Applicants Compete For Limited Funding

February 1, 1991

NCAB Working Group Renamed, Adds Karen Antman

December 16, 1994

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007